Lymphocyte Activation Gene-3, a MHC Class II Ligand Expressed on Activated T Cells, Stimulates TNF-α and IL-12 Production by Monocytes and Dendritic Cells
Author:
Affiliation:
1. *Laboratoire de Recherche sur l’Allergie, Université de Montréal, Centre de Recherche Louis-Charles Simard, Montréal, Québec, Canada; and
2. †Unité d’Immunologie Cellulaire, Institut Gustave-Roussy, Villejuif, France
Abstract
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Link
https://journals.aai.org/jimmunol/article-pdf/162/5/2748/1101687/im059902748o.pdf
Reference34 articles.
1. Triebel, F., S. Jitsukawa, E. Baixeras, R. S. Roman, C. Genevee, P. E. Viegas, T. Hercend. 1990. LAG-3, a novel lymphocyte activation gene closely related to CD4. J. Exp. Med. 171: 1393
2. Baixeras, E., B. Huard, C. Miossec, S. Jitsukawa, M. Martin, T. Hercend, C. Auffray, F. Triebel, T. D. Piatier. 1992. Characterization of the lymphocyte activation gene 3-encoded protein: a new ligand for human leukocyte antigen class II antigens. J. Exp. Med. 176: 327
3. Hannier, S., M. Tournier, G. Bismuth, F. Triebel. 1998. CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. J. Immunol. 161: 4058
4. Huard, B., P. Prigent, M. Tournier, D. Bruniquel, F. Triebel. 1995. CD4/major histocompatibility complex class II interaction analyzed with CD4− and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins. Eur. J. Immunol. 25: 2718
5. Glaichenhaus, N., N. Shastri, D. R. Littman, J. M. Turner. 1991. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell 64: 511
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Emerging Immune Checkpoint Inhibitors for the Treatment of Oropharyngeal Squamous Cell Carcinoma;Oral Oncology Reports;2024-09
2. Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review;Frontiers in Oncology;2024-08-26
3. Soluble form of immune checkpoints in autoimmune diseases;Journal of Autoimmunity;2024-07
4. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31
5. Emerging monoclonal antibody therapy for head and neck squamous cell carcinoma;Expert Opinion on Emerging Drugs;2024-04-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3